{"id":245713,"date":"2026-09-15T10:27:19","date_gmt":"2026-09-15T04:57:19","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=245713"},"modified":"2026-09-15T10:27:19","modified_gmt":"2026-09-15T04:57:19","slug":"why-corona-remedies-ltd-share-price-52-week-high-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-corona-remedies-ltd-share-price-52-week-high-today-2026\/","title":{"rendered":"CORONA Remedies Ltd. (CORONA): CORONA Remedies Share Price hits fresh 52-week high on 15 September 2026"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/corona\/corona-remedies-ltd-share-price-today\">CORONA Remedies Ltd. (CORONA)<\/a> share price reached a fresh 52-week high of Rs 2,285 today and later stood at Rs 2,255.4, up 0.85% from the previous close. Market cap was Rs 13,677.23 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\">CORONA Remedies Share Price was at Rs 2,255.40, up 0.85% from the previous close, after touching a fresh 52-week high of Rs 2,285. The company\u2019s market capitalisation stood at Rs 13,677.23 Cr as the stock stayed in focus in today\u2019s stock news. According to latest Univest data, the move confirms the 52-week high event, but it does not establish a company-specific catalyst. For investors tracking CORONA Remedies Share Price Today, the key question is how the current price, valuation and sector comparison fit together in the latest market update.<\/p>\n<p style=\"margin-top:0!important;\">The stock opened at Rs 2,236 and moved between Rs 2,197.90 and Rs 2,285 during the morning session. The latest Univest figures also show turnover of Rs 0.93 Cr. CORONA Remedies Share Price is now being watched for how it behaves around the yearly high, while Univest data also places the stock\u2019s valuation and operating metrics in the broader healthcare context.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-corona-remedies-ltd-share-price-52-week-high-today-2026\/#CORONA_Remedies_Share_Price_Today_Price_Action_Analysis\" title=\"CORONA Remedies Share Price Today: Price Action Analysis\">CORONA Remedies Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-corona-remedies-ltd-share-price-52-week-high-today-2026\/#CORONA_Remedies_Ltd_CORONA_Fundamental_Analysis\" title=\"CORONA Remedies Ltd. (CORONA) Fundamental Analysis\">CORONA Remedies Ltd. (CORONA) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-corona-remedies-ltd-share-price-52-week-high-today-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-corona-remedies-ltd-share-price-52-week-high-today-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-corona-remedies-ltd-share-price-52-week-high-today-2026\/#Why_Investors_Are_Watching_CORONA_Remedies\" title=\"Why Investors Are Watching CORONA Remedies\">Why Investors Are Watching CORONA Remedies<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-corona-remedies-ltd-share-price-52-week-high-today-2026\/#About_CORONA_Remedies\" title=\"About CORONA Remedies\">About CORONA Remedies<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-corona-remedies-ltd-share-price-52-week-high-today-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-corona-remedies-ltd-share-price-52-week-high-today-2026\/#What_is_CORONA_Remedies_Share_Price_today\" title=\"What is CORONA Remedies Share Price today?\">What is CORONA Remedies Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-corona-remedies-ltd-share-price-52-week-high-today-2026\/#Did_CORONA_Remedies_Share_Price_hit_a_fresh_52-week_high\" title=\"Did CORONA Remedies Share Price hit a fresh 52-week high?\">Did CORONA Remedies Share Price hit a fresh 52-week high?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-corona-remedies-ltd-share-price-52-week-high-today-2026\/#What_is_the_market_capitalisation_of_CORONA_Remedies\" title=\"What is the market capitalisation of CORONA Remedies?\">What is the market capitalisation of CORONA Remedies?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-corona-remedies-ltd-share-price-52-week-high-today-2026\/#How_does_CORONA_Remedies_compare_with_the_healthcare_industry_valuation\" title=\"How does CORONA Remedies compare with the healthcare industry valuation?\">How does CORONA Remedies compare with the healthcare industry valuation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-corona-remedies-ltd-share-price-52-week-high-today-2026\/#What_do_ROE_and_ROCE_show_for_CORONA_Remedies\" title=\"What do ROE and ROCE show for CORONA Remedies?\">What do ROE and ROCE show for CORONA Remedies?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-corona-remedies-ltd-share-price-52-week-high-today-2026\/#What_earnings_and_book_value_figures_are_reported\" title=\"What earnings and book value figures are reported?\">What earnings and book value figures are reported?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-corona-remedies-ltd-share-price-52-week-high-today-2026\/#Is_dividend_yield_part_of_the_CORONA_Remedies_profile\" title=\"Is dividend yield part of the CORONA Remedies profile?\">Is dividend yield part of the CORONA Remedies profile?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-corona-remedies-ltd-share-price-52-week-high-today-2026\/#Where_can_investors_track_CORONA_Remedies_Share_Price_on_Univest\" title=\"Where can investors track CORONA Remedies Share Price on Univest?\">Where can investors track CORONA Remedies Share Price on Univest?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-corona-remedies-ltd-share-price-52-week-high-today-2026\/#Track_CORONA_Remedies_Share_Price_on_Univest\" title=\"Track CORONA Remedies Share Price on Univest\">Track CORONA Remedies Share Price on Univest<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"CORONA_Remedies_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>CORONA Remedies Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,255.4<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,236.3<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 19.1 (+0.85%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,236<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,285<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,197.9<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 0.93 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 13,677.23 crore<\/td>\n<\/tr>\n<\/table>\n<p>CORONA Remedies Ltd. (CORONA) traded at Rs 2,255.4 versus the previous close of Rs 2,236.3, a rise of 0.85%. The stock opened at Rs 2,236, reached a high of Rs 2,285 and touched a low of Rs 2,197.9.<\/p>\n<p>CORONA Remedies Share Price Today reflected a gain of Rs 19.10 from the previous close of Rs 2,236.30, with the stock last traded at Rs 2,255.40. The day open was Rs 2,236, and the price range stretched from Rs 2,197.90 to Rs 2,285, which is also the fresh 52-week high. On the current reading, the stock is trading Rs 29.60 below that peak after first touching it intraday. Turnover stood at Rs 0.93 Cr, and the latest Univest data confirms the event without assigning a cause. For readers following CORONA Remedies Share Price News, this is the main price development to note today.<\/p>\n<p>Since the previous 52-week high was not supplied, no breakout percentage is calculated here. What matters for CORONA Remedies Share Price is that the stock has already reached a one-year high while still trading within the same morning range. That keeps CORONA Remedies Share Price in the stock news flow on Univest and in broader share market today searches.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"CORONA_Remedies_Ltd_CORONA_Fundamental_Analysis\"><\/span><strong>CORONA Remedies Ltd. (CORONA) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 13,677.23 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">68.72x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">16.95x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.36%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.74%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 32.54<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 131.94<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.45%<\/td>\n<\/tr>\n<\/table>\n<p>CORONA Remedies Ltd. (CORONA) fundamental metrics show P\/E 68.72x, P\/B 16.95x, ROE 27.36%, ROCE 31.74%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>CORONA Remedies Ltd. has a market capitalisation of Rs 13677.23 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 68.72x, P\/B at 16.95x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 27.36% and ROCE of 31.74%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 32.54, book value per share of Rs 131.94, dividend yield of 0.45%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 32.41x, median ROE of 11.61%, median ROCE of 13.18%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">68.72x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">32.41x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">49.04x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.34x to 693.7x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">16.95x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.04x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.36%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.61%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.74%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.18%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 13,677.23 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 692.38 crore<\/td>\n<\/tr>\n<\/table>\n<p>CORONA Remedies Ltd. (CORONA) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>CORONA Remedies Ltd. (CORONA) has a P\/E ratio of 68.72x, which is above the benchmark median of 32.41x, a difference of +112.03%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>CORONA Remedies Ltd. (CORONA) has a ROE of 27.36%, which is above the benchmark median of 11.61%, a difference of +135.66%. CORONA Remedies Ltd. (CORONA) has a ROCE of 31.74%, which is above the benchmark median of 13.18%, a difference of +140.82%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sudeepphrm\/sudeep-pharma-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sudeep Pharma Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUDEEPPHRM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13,560.61<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">74.25<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.68<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.37<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">28.5<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/natcopharm\/natco-pharma-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Natco Pharma Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">NATCOPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14,599.25<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1.56<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.3<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">17.16<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/marksans\/marksans-pharma-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Marksans Pharma Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">MARKSANS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14,877.37<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">28.79<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.68<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.1<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/akums\/akums-drugs-and-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Akums Drugs &amp; Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">AKUMS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12,216.92<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">41.88<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.58<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.06<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.77<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/concordbio\/concord-biotech-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Concord Biotech Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CONCORDBIO<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15,762<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">57.24<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7.6<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.54<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.04<\/td>\n<\/tr>\n<\/table>\n<p>CORONA Remedies Ltd. (CORONA) has a P\/E ratio of 68.72x compared with the displayed peer median of 41.88x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 27.36% compares with a peer median of 15.31% across the companies shown in the table. ROCE stood at 31.74% versus the displayed peer median of 18.04%, providing a capital-efficiency comparison. CORONA Remedies Ltd. (CORONA) has a market capitalisation of Rs 13,677.23 crore. Among the 5 peers shown, 3 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_CORONA_Remedies\"><\/span><strong>Why Investors Are Watching CORONA Remedies<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>CORONA Remedies Share Price touched a fresh 52-week high of Rs 2,285 during the morning session.<\/li>\n<li>CORONA Remedies Share Price Today was last traded at Rs 2,255.40, up Rs 19.10 from the previous close.<\/li>\n<li>Market capitalisation stood at Rs 13,677.23 Cr in the latest Univest figures.<\/li>\n<li>P\/E at 68.72 and P\/B at 16.95 are both above the healthcare industry median.<\/li>\n<li>ROE of 27.36% and ROCE of 31.74% are above the industry medians in the same industry benchmark.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_CORONA_Remedies\"><\/span><strong>About CORONA Remedies<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>CORONA Remedies Ltd. operates in the healthcare sector and the pharmaceuticals &amp; drugs industry. CORONA Remedies Share Price is therefore read alongside a business profile that sits within one of India\u2019s most closely tracked healthcare market groups. For Univest readers, CORONA Remedies Stock News today is mainly tied to the fresh 52-week high and the company\u2019s valuation and return ratios.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_CORONA_Remedies_Share_Price_today\"><\/span><strong>What is CORONA Remedies Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> CORONA Remedies Share Price was last traded at Rs 2,255.40, up 0.85% from the previous close of Rs 2,236.30. The stock also touched a fresh 52-week high of Rs 2,285 in the morning session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_CORONA_Remedies_Share_Price_hit_a_fresh_52-week_high\"><\/span><strong>Did CORONA Remedies Share Price hit a fresh 52-week high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes. CORONA Remedies Share Price touched Rs 2,285, which is the fresh 52-week high for the session. The current price remained below that peak at Rs 2,255.40 when last updated.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_CORONA_Remedies\"><\/span><strong>What is the market capitalisation of CORONA Remedies?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> CORONA Remedies had a market capitalisation of Rs 13,677.23 Cr. This places CORONA Remedies Share Price within the larger healthcare market-cap bracket tracked in the latest Univest data.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_CORONA_Remedies_compare_with_the_healthcare_industry_valuation\"><\/span><strong>How does CORONA Remedies compare with the healthcare industry valuation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> CORONA Remedies Share Price trades at a P\/E of 68.72 and P\/B of 16.95, both above the industry median. That makes the valuation richer than the same-industry benchmark of 203 companies.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_ROE_and_ROCE_show_for_CORONA_Remedies\"><\/span><strong>What do ROE and ROCE show for CORONA Remedies?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> CORONA Remedies reported ROE of 27.36% and ROCE of 31.74%. Both are above the healthcare industry medians, which gives CORONA Remedies Share Price a stronger return-ratio profile than many peers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_earnings_and_book_value_figures_are_reported\"><\/span><strong>What earnings and book value figures are reported?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The latest figures show EPS of 32.54 and book value of Rs 131.94. Those numbers help frame CORONA Remedies Share Price alongside the company\u2019s valuation and return ratios.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_dividend_yield_part_of_the_CORONA_Remedies_profile\"><\/span><strong>Is dividend yield part of the CORONA Remedies profile?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes. CORONA Remedies Share Price data includes a dividend yield of 0.45%. It is a factual current measure and should be read together with valuation, EPS and book value.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_investors_track_CORONA_Remedies_Share_Price_on_Univest\"><\/span><strong>Where can investors track CORONA Remedies Share Price on Univest?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors can track CORONA Remedies Share Price on Univest for live price updates, 52-week levels, valuation ratios, company financials, sector context and the latest stock news in one place.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is CORONA Remedies Share Price today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"CORONA Remedies Share Price was last traded at Rs 2,255.40, up 0.85% from the previous close of Rs 2,236.30. The stock also touched a fresh 52-week high of Rs 2,285 in the morning session.\"}},{\"@type\":\"Question\",\"name\":\"Did CORONA Remedies Share Price hit a fresh 52-week high?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes. CORONA Remedies Share Price touched Rs 2,285, which is the fresh 52-week high for the session. The current price remained below that peak at Rs 2,255.40 when last updated.\"}},{\"@type\":\"Question\",\"name\":\"What is the market capitalisation of CORONA Remedies?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"CORONA Remedies had a market capitalisation of Rs 13,677.23 Cr. This places CORONA Remedies Share Price within the larger healthcare market-cap bracket tracked in the latest Univest data.\"}},{\"@type\":\"Question\",\"name\":\"How does CORONA Remedies compare with the healthcare industry valuation?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"CORONA Remedies Share Price trades at a P\/E of 68.72 and P\/B of 16.95, both above the industry median. That makes the valuation richer than the same-industry benchmark of 203 companies.\"}},{\"@type\":\"Question\",\"name\":\"What do ROE and ROCE show for CORONA Remedies?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"CORONA Remedies reported ROE of 27.36% and ROCE of 31.74%. Both are above the healthcare industry medians, which gives CORONA Remedies Share Price a stronger return-ratio profile than many peers.\"}},{\"@type\":\"Question\",\"name\":\"What earnings and book value figures are reported?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The latest figures show EPS of 32.54 and book value of Rs 131.94. Those numbers help frame CORONA Remedies Share Price alongside the company\u2019s valuation and return ratios.\"}},{\"@type\":\"Question\",\"name\":\"Is dividend yield part of the CORONA Remedies profile?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes. CORONA Remedies Share Price data includes a dividend yield of 0.45%. It is a factual current measure and should be read together with valuation, EPS and book value.\"}},{\"@type\":\"Question\",\"name\":\"Where can investors track CORONA Remedies Share Price on Univest?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors can track CORONA Remedies Share Price on Univest for live price updates, 52-week levels, valuation ratios, company financials, sector context and the latest stock news in one place.\"}}]}<\/script><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Track_CORONA_Remedies_Share_Price_on_Univest\"><\/span><strong>Track CORONA Remedies Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/corona\/corona-remedies-ltd-share-price-today\">CORONA Remedies Ltd. (CORONA) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<p>Track CORONA Remedies Share Price Live on Univest for the latest share price update, 52-week high level, market capitalisation, company financials, valuation ratios, sector analysis and other market insights. Univest also helps users follow CORONA Remedies Share Price Today, CORONA Remedies Latest News and CORONA Remedies Fundamental Analysis in one place.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>CORONA Remedies Ltd. Share Price hits a new 52-week high at Rs 2,255.4, marking a 0.85% rise today. Market cap stands at Rs 13,677.23 crore.<\/p>\n","protected":false},"author":29,"featured_media":245710,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-245713","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["245710"],"rank_math_title":["CORONA Remedies Share Price Today at Fresh 52-Week High"],"rank_math_description":["CORONA Remedies Share Price touched a fresh 52-week high of Rs 2,285. Read today's price action, valuation, sector benchmark and peers."],"rank_math_focus_keyword":["CORONA Remedies Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/CORONA_Remedies_Ltd_CORONA_CORONA_Remedies_Share_Price_hits_fresh_52_week_high_on_15_September_2026_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/245713","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=245713"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/245713\/revisions"}],"predecessor-version":[{"id":245714,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/245713\/revisions\/245714"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/245710"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=245713"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=245713"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=245713"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}